Amber Tong

China has pledged to encourage more research in gene and cell therapies at the country’s biotech hub in the eastern Chinese city of Suzhou, in the latest bid to bolster the country’s standing at the cutting edge of global drug research.

Drugmaker sees revenue growing 6% per year through to 2029

China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance, a move that will boost the British drugmaker’s sales in the country in the midst of an ongoing probe that’s ensnared some of its senior executives.

China approved AstraZeneca Plc 's blockbuster breast cancer treatment for reimbursement by state-run medical insurance amid an ongoing probe into its illegal sales practices, in a reassuring sign for the British drugmaker's wider business.

At a time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical dealmaking has become a rare bright spot for collaboration between China and the West. Industry watchers are holding their breath to see how the incoming Trump administration changes that.

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest single investment in China to date and part of a broader push to boost manufacturing capacity in Asia.

Shares of WuXi AppTec Co. and WuXi Biologics Cayman Inc. surged Monday, after a draft US legislation targeting the Chinese biotechnology service firms was left out of a key defense bill.

Even as Americans live longer, they spend more of their years in poor health than any other country, a new study shows.

December 11, 2024 Even as Americans live longer, they spend more of their years in poor health than any other country, a new study shows.

China’s aggressive drive to replace brand-name foreign drugs with dirt-cheap homegrown generics has already taken a toll on global pharmaceutical companies’ local business. Now they’re almost nowhere to be found on the latest list of companies winning contracts to sell commonly-used drugs to Chinese hospitals.